Shanghai Chenguang Medical Technology Co., Ltd. (stock abbreviation: Chenguang Medical, stock code: 430300) was established in 2004 with a registered capital of 68,597,126 million yuan. It is a company dedicated to the core components of the high-field and ultra-high-field magnetic resonance industry chain for a long time. Independent and innovative high-tech enterprises in R&D, production, sales and maintenance, and small giant enterprises in Shanghai. There are about 230 employees, including 6 doctors and 8 masters. The company has over 34,000 square meters of high-sensitivity magnetic resonance core components R&D and production base in Qingpu Park, Zhangjiang High-tech Industrial Development Zone, Shanghai. Its three subsidiaries are Chenshi Medical, Chenzhan Medical, and Chenhao Superconductor. The products cover the core components of magnetic resonance (1.5T, 3.0T, 7.0T) radio frequency systems, gradient systems, superconducting magnets, and superconducting, normally conductive magnets, cryogenic equipment, vacuum semiconductor equipment, etc.

        The project leaders of Chenguang Medical have rich experience in the development, design and production of superconducting magnetic resonance core components at home and abroad. The magnetic resonance core components designed and produced by them have been used in the magnetics produced by domestic and foreign mainstream MRI companies. On the resonance system. The magnetic resonance radio frequency detector independently developed and produced by Chenguang Medical filled the domestic gap when it entered the Chinese medical device product registration. The company also pioneered the development of a variety of experimental special radio frequency coils for cutting-edge scientific research. Relying on its leading comprehensive engineering capabilities, after years of research and development, Chenguang Medical has overcome technical difficulties in multiple core components in the 1.5T, 3.0T and 7.0T magnetic resonance systems. Currently, more than 80 patented technologies are applied In the research and development and production of core components of magnetic resonance, the products have broken the monopoly of similar international products in China and successfully realized import substitution. The MR platform solutions provided by the company for Chinese MRI system vendors are comparable to well-known multinational MRI systems.

        Chenguang Medical is committed to operating in compliance with laws and regulations, has established advanced quality system specifications, and has obtained the qualifications for domestic and international market access. The company has passed ISO13485, ISO14001 and European CE certification. Our self-developed core products have passed the China Food and Drug Administration SFDA certification and UL safety certification. At the same time, products exported to Europe, the United States, Japan and other countries also have the US Food and Drug Administration FDA certification and Japan PAL certification.

        Chenguang Medical will continue to enhance the company's advanced position in the fields of superconducting magnetic resonance radio frequency detectors, superconducting magnets, etc., and gradually expand the industry chain and application fields of superconducting magnetic resonance, and transform from a component manufacturer to a diversified production and service enterprise , And strive to build "Chenguang Medical" into a Chinese MRI brand comparable to multinational companies.